Patents by Inventor Avelino Teixeira

Avelino Teixeira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150037281
    Abstract: The present invention relates to novel Prothymosin Alpha (ProT?) variants that are capable of inducing cell-mediated immune responses. These variants lack a nuclear localization signal and the proliferative oncogenic activity previously attributed to ProT?. The variants of the invention are used in methods of treating, for example, viral infections, bacterial infections, fungal infections, cancer, ischemia and myeloproliferative blood disorders. Administration of a ProT? variant to a subject in a therapeutically effective amount treats the infection or disease.
    Type: Application
    Filed: March 1, 2013
    Publication date: February 5, 2015
    Applicant: Icahn School of Medicine at Mount Sinai
    Inventors: Arevik Mosoian, Avelino Teixeira
  • Patent number: 7754687
    Abstract: The present invention is directed to methods of preventing and/or treating infectious disease. In a particular aspect, the invention is directed to treating viral infections by administering an isolated Prothymosin alpha molecule (SEQ ID NO: 2) to a subject in a therapeutically effective amount that reduces the symptoms associated with the viral infection. In a more particular embodiment, the viral infection is caused by a retrovirus, a lentivirus, or a hepatitis virus. In a particular aspect, the viral infection is caused by human immunodeficiency virus-1.
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: July 13, 2010
    Assignee: Mount Sinai School of Medicine
    Inventors: Arevik Mosoian, Mary E. Klotman, Avelino Teixeira
  • Publication number: 20060258565
    Abstract: The present invention is directed to methods of preventing and/or treating infectious disease. In a particular aspect, the invention is directed to preventing and/or treating viral infections.
    Type: Application
    Filed: February 23, 2006
    Publication date: November 16, 2006
    Inventors: Arevik Mosoian, Marry Klotman, Avelino Teixeira